Tiziana Life Sciences Ltd (TLSA)Healthcare | Biotechnology | London, United Kingdom | NasdaqCM
1.24 USD
-0.10
(-7.463%) ⇩
(April 17, 2026, 4 p.m.
EDT)
After hours: 1.28 +0.04 (3.194%) ⇧ (April 17, 2026, 7:31 p.m. EDT) Short-term: ★★☆☆☆ | Long-term: ★☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 11, 2026, 3:26 p.m. EDT
TLSA appears to be a high-risk, speculative play with significant volatility and weak fundamentals. The recent news about clinical trials and fundraising efforts may provide short-term momentum, but the lack of consistent earnings and dividend history makes it unsuitable for long-term investment. The options market suggests potential for a strong upward move, but the low liquidity and poor financials make it a risky proposition for most investors. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.138928 |
| AutoETS | 0.149021 |
| AutoARIMA | 0.149432 |
| AutoTheta | 0.186516 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 50% |
| H-stat | 3.86 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.120 |
| Excess Kurtosis | -0.09 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 1.163 |
| Market Cap | 157,786,784 |
| Forward P/E | -6.20 |
| Beta | 0.37 |
| Previous Name | Tiziana Life Sciences PLC |
| Website | https://www.tizianalifesciences.com |
As of April 11, 2026, 3:26 p.m. EDT: The options activity indicates a strong bias towards calls, particularly for strikes significantly above the current price. The high open interest and volume for out-of-the-money (OTM) calls, especially for the June 18 expiration, suggest that speculators are anticipating a substantial upward move. The low implied volatility (IV) for puts suggests less bearish sentiment. However, the overall market fundamentals are weak, with negative earnings and low liquidity, which could limit the upside potential.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.097345114 |
| Address1 | 14/15 Conduit Street |
| All Time High | 12.17 |
| All Time Low | 0.41 |
| Ask | 1.28 |
| Ask Size | 1 |
| Average Daily Volume10 Day | 199,160 |
| Average Daily Volume3 Month | 177,030 |
| Average Volume | 177,030 |
| Average Volume10Days | 199,160 |
| Beta | 0.373 |
| Bid | 1.21 |
| Bid Size | 1 |
| Book Value | 0.077 |
| City | London |
| Compensation As Of Epoch Date | 1,735,603,200 |
| Country | United Kingdom |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.24 |
| Current Ratio | 1.719 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 1.38 |
| Day Low | 1.22 |
| Debt To Equity | 1.163 |
| Display Name | Tiziana Life Sciences |
| Earnings Timestamp End | 1,752,004,800 |
| Earnings Timestamp Start | 1,750,708,800 |
| Ebitda | -18,464,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -7.593 |
| Enterprise Value | 140,197,776 |
| Eps Current Year | -0.133 |
| Eps Forward | -0.2001404 |
| Eps Trailing Twelve Months | -0.12 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 1.3228 |
| Fifty Day Average Change | -0.08280003 |
| Fifty Day Average Change Percent | -0.06259452 |
| Fifty Two Week Change Percent | 9.734511 |
| Fifty Two Week High | 2.6 |
| Fifty Two Week High Change | -1.3599999 |
| Fifty Two Week High Change Percent | -0.5230769 |
| Fifty Two Week Low | 1.01 |
| Fifty Two Week Low Change | 0.23000002 |
| Fifty Two Week Low Change Percent | 0.2277228 |
| Fifty Two Week Range | 1.01 - 2.6 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,542,724,200,000 |
| Float Shares | 64,808,990 |
| Forward Eps | -0.2001404 |
| Forward P E | -6.1956506 |
| Free Cashflow | -3,856,625 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 9 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.43948 |
| Held Percent Institutions | 0.03145 |
| Implied Shares Outstanding | 127,247,402 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,735,603,200 |
| Last Split Date | 1,596,153,600 |
| Last Split Factor | 2,499:1000 |
| Long Business Summary | Tiziana Life Sciences Ltd, a biotechnology company, engages in the development of transformative therapies for neurodegenerative and lung diseases in the United States. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for use in the treatment of Crohn's, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel, psoriasis, and rheumatoid arthritis diseases. It is also developing TZLS-501, a fully human mAb targeting the IL-6 receptor for use in the treatment of inflammatory and oncology indications. Tiziana Life Sciences Ltd was incorporated in 1998 and is headquartered in London, the United Kingdom. |
| Long Name | Tiziana Life Sciences Ltd |
| Market | us_market |
| Market Cap | 157,786,784 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_261234197 |
| Most Recent Quarter | 1,751,241,600 |
| Name Change Date | 2,026-04-18 |
| Net Income To Common | -12,841,000 |
| Next Fiscal Year End | 1,767,139,200 |
| Non Diluted Market Cap | 157,786,777 |
| Number Of Analyst Opinions | 1 |
| Open | 1.35 |
| Operating Cashflow | -8,749,000 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 44 20 7495 2379 |
| Post Market Change | 0.039600015 |
| Post Market Change Percent | 3.1935496 |
| Post Market Price | 1.2796 |
| Post Market Time | 1,776,468,666 |
| Prev Name | Tiziana Life Sciences PLC |
| Previous Close | 1.34 |
| Price Eps Current Year | -9.323308 |
| Price Hint | 4 |
| Price To Book | 16.103897 |
| Profit Margins | 0.0 |
| Quick Ratio | 1.649 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.1 |
| Regular Market Change Percent | -7.46269 |
| Regular Market Day High | 1.38 |
| Regular Market Day Low | 1.22 |
| Regular Market Day Range | 1.22 - 1.38 |
| Regular Market Open | 1.35 |
| Regular Market Previous Close | 1.34 |
| Regular Market Price | 1.24 |
| Regular Market Time | 1,776,456,000 |
| Regular Market Volume | 325,752 |
| Return On Assets | -0.83782 |
| Return On Equity | -2.32311 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 127,247,401 |
| Shares Percent Shares Out | 0.0114 |
| Shares Short | 1,456,539 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 1,529,567 |
| Short Name | Tiziana Life Sciences Ltd |
| Short Percent Of Float | 0.0171 |
| Short Ratio | 10.02 |
| Source Interval | 15 |
| Symbol | TLSA |
| Target High Price | 8.018026 |
| Target Low Price | 8.018026 |
| Target Mean Price | 8.018026 |
| Target Median Price | 8.018026 |
| Total Cash | 7,251,000 |
| Total Cash Per Share | 0.061 |
| Total Debt | 107,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.12 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 1.6664 |
| Two Hundred Day Average Change | -0.42639995 |
| Two Hundred Day Average Change Percent | -0.25588092 |
| Type Disp | Equity |
| Volume | 325,752 |
| Website | https://www.tizianalifesciences.com |
| Zip | W1S 2XJ |